DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 200 filers reported holding EDITAS MEDICINE INC in Q1 2018. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q4 2020$37,770,000
+36.1%
538,721
-45.5%
0.75%
+10.4%
Q3 2020$27,747,000
-19.1%
988,841
-14.7%
0.68%
-32.3%
Q2 2020$34,279,000
+49.2%
1,158,8410.0%1.00%
+36.9%
Q1 2020$22,980,000
-33.0%
1,158,8410.0%0.73%
-33.4%
Q4 2019$34,313,000
+30.2%
1,158,8410.0%1.10%
+2.0%
Q3 2019$26,352,000
-8.1%
1,158,8410.0%1.07%
+4.3%
Q2 2019$28,670,000
+1.2%
1,158,8410.0%1.03%
-5.2%
Q1 2019$28,334,000
+7.5%
1,158,8410.0%1.09%
+3.0%
Q4 2018$26,364,000
-28.5%
1,158,8410.0%1.06%
-20.1%
Q3 2018$36,874,000
-11.2%
1,158,8410.0%1.32%
-9.4%
Q2 2018$41,521,000
+8.1%
1,158,8410.0%1.46%
+9.5%
Q1 2018$38,416,000
-26.9%
1,158,841
-32.2%
1.33%
-35.6%
Q4 2017$52,530,000
+28.0%
1,709,4000.0%2.07%
+11.8%
Q3 2017$41,043,000
+43.1%
1,709,4000.0%1.85%
+20.8%
Q2 2017$28,684,000
-24.8%
1,709,4000.0%1.53%
+3.9%
Q1 2017$38,154,000
+37.5%
1,709,4000.0%1.47%
+28.9%
Q4 2016$27,744,000
+20.4%
1,709,4000.0%1.14%
+6.5%
Q3 2016$23,043,000
-44.8%
1,709,4000.0%1.07%
-34.6%
Q2 2016$41,709,000
-29.4%
1,709,4000.0%1.64%
-34.8%
Q1 2016$59,043,0001,709,4002.51%
Other shareholders
EDITAS MEDICINE INC shareholders Q1 2018
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 1,674,435$51,455,00013.05%
TRV GP III, LLC 906,176$27,847,0009.75%
ARK Investment Management 1,112,845$34,198,0002.72%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,709,400$52,530,0002.07%
Casdin Capital, LLC 133,333$4,097,0001.00%
Global Thematic Partners, LLC 614,052$18,869,0000.62%
MORGENS WATERFALL VINTIADIS & CO INC 20,000$615,0000.48%
Ghost Tree Capital, LLC 65,000$1,997,0000.47%
ACUTA CAPITAL PARTNERS, LLC 64,000$1,967,0000.37%
VIKING GLOBAL INVESTORS LP 1,709,401$52,530,0000.32%
View complete list of EDITAS MEDICINE INC shareholders